[1] Rivera C.Essentials of oral cancer[J]. Int J Clin Exp Patho, 2015, 8(9): 11884-11894. [2] Ackerman LV.Verrucous carcinoma of the oral cavity[J]. Surgery, 1948, 23(4): 670-678. [3] 李涛, 李敏, 姬新颖, 等. 肿瘤坏死因子α诱导蛋白家族与疾病的关系[J]. 细胞与分子免疫学杂志, 2014, 30(4):433-436. [4] Day JA, Milner MC.TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties[J]. Matrix Biol, 2019, (78-79): 60-83. [5] Zhang Y, He W, Zhang S.Seeking for correlative genes and signaling pathways with bone metastasis from breast cancer by integrated analysis[J]. Front Oncol, 2019, 9: 138. [6] Wang G, Cao K, Liu K, et al.Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells[J]. Cell Death Differ, 2018, 25(7): 1209-1223. [7] Chan TC, Li CF, Ke HL, et al. High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas[J]. Urol Oncol, 2019, 37(4): 293.e11-293.e24. [8] Masson-Lecomte A, Rava M, Real FX, et al.Inflammatory biomarkers and bladder cancer prognosis: a systematic review[J]. Eur Urol, 2014, 66(6): 1078-1091. [9] 王月红. 口腔疣状癌、口腔鳞癌全基因组及miRNA表达谱研究[D]. 长沙: 中南大学, 2012. [10] 许良中, 杨文涛. 免疫组织化学反应结果的判断标准[J]. 中国癌症杂志, 1996, 6(4): 229-231. [11] Wu T, Dai Y.Tumor microenvironment and therapeutic response[J]. Cancer Lett, 2017, 387: 61-68. [12] Shalapour S, Karin M.Immunity, inflammation, and cancer: an eternal fight between good and evil[J]. J Clin Invest, 2015, 125(9): 3347-3355. [13] Naik PP, Panda PK, Bhutia SK.Oral cancer stem cells microenvironment[J]. Adv Exp Med Biol, 2017,1041: 207-233. [14] Dmitrieva OS, Shilovskiy IP, Khaitov MR, et al.Interleukins 1 and 6 as main mediators of inflammation and cancer[J]. Biochemistry(Mosc), 2016, 81(2): 80-90. [15] Westbrook AM, Szakmary A, Schiestl RH.Mouse models of intestinal inflammation and cancer[J]. Arch Toxicol, 2016, 90(9): 2109-2130. [16] Milner CM, Day AJ.TSG-6: a multifunctional protein associated with inflammation[J]. J Cell Sci, 2003, 116(Pt 10): 1863-1873. [17] Dyer DP, Thomson JM, Hermant A, et al.TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8[J]. J Immunol, 2014, 192(5): 2177-2185. [18] Lesley J, Gál I, Mahoney DJ, et al.TSG-6 modulates the interaction between hyaluronan and cell surface CD44[J]. J Bio Chem, 2004, 279(24): 25745-25754. [19] Lawrance W, Banerji S, Day AJ, et al.Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization[J]. J Bio Chem, 2016, 291(15): 8014-8030. [20] Passi A, Vigetti D, Buraschi S, et al.Dissecting the role of hyaluronan synthases in the tumor microenvironment[J]. FEBS J, 2019, 286(15): 2937-2949. [21] Chou CH, Attarian DE, Wisniewski HG, et al.TSG-6-a double-edged sword for osteoarthritis[J]. Osteo Cartilage, 2018, 26(2): 245-254. |